The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Category Archives: Transhuman News
Electric DNA, Circular RNA, and Other Epigenetic Wonders – Discovery Institute
Posted: April 3, 2017 at 7:51 pm
Upon completion of the Human Genome Project, scientists were baffled at the unexpectedly low number of genes. How could so few protein-coding genes (about 20,000) build a human being?It turned out that genes are only one part of the action. The old Central Dogma that viewed DNA as the master molecule, RNA as the messenger boy, and protein as the end product is long gone. Now we are beginning to see that there are three -omes that interact in complex ways with other molecules, including lipids and sugars. Everywhere they turn, scientists are seeing molecular wizardry at work. Here are just a few recent examples.
Another -Ome with a Code of Its Own
The Bellvitge Biomedical Research Institute (IDIBELL) of Barcelona, Spain, assumes we know about the genome and the epigenome. Now, news from IDIBELL draws our attention to another -ome that is rising in significance: the transcriptome, referring to the epigenetics of RNA:
It is well-known that sometimes DNA produces a RNA string but then this RNA does not originate the protein. Because in these cases the alteration is neither in the genome nor the proteome, we thought it should be in the transcriptome, that is, in the RNA molecule, Dr. Esteller explains.In recent years, we discovered that our RNA is highly regulated and if only two or three modifications at the DNA level can control it, there may be hundreds of small changes in RNA that control its stability, its intracellular localization or its maturation in living beings. [Emphasis added.]
For example, some non-coding RNAs are now known to be guardian RNAs according to the modifications on their bases or sugars with methyl groups that act as tags. The field of transcriptomics is only about five years old; It will definitely be an exciting research stage for this and the next generation of scientists, Dr. Esteller says. See our recent article RNA Code Surpassing DNA in Complexity for more about this epicentric karma running over the Central Dogma.
Electric DNA
Heres another way that DNA carries information that is rather shocking: it conducts electricity. Science Magazine describes DNA charge transport as an unexpected signaling system between the code and its reading machines.
DNA charge transport provides an avenue for rapid, long-range signaling between redox-active moieties coupled into the DNA duplex. Several enzymes integral to eukaryotic DNA replication contain [4Fe4S] clusters, common redox cofactors. DNA primase, the enzyme responsible for initiating replication on single-stranded DNA, is a [4Fe4S] protein. Primase synthesizes short RNA primers of a precise length before handing off the primed DNA template to DNA polymerase , another [4Fe4S] enzyme. The [4Fe4S] cluster in primase is required for primer synthesis, but its underlying chemistry has not been established. Moreover, what orchestrates primer handoff between primase and DNA polymerase is not well understood.
In the paper, seven researchers from Caltech and Vanderbilt tell about experiments they ran to establish the existence of electrical charge transfers between the double helix and the molecular machines that read it and duplicate it. We demonstrate that the oxidation state of the [4Fe4S] cluster in DNA primase acts as a reversible on/off switch for DNA binding, they conclude. And its not alone. Because DNA can conduct charges over long distances, Such redox signaling by [4Fe4S] clusters may play a wider role in polymerase enzymes to coordinate eukaryotic DNA replication.
Circular RNA
Some RNAs fold into stable loops. We have them in our brains. What do they do? When discovered, they were considered non-coding. Now, however, scientists at Hebrew University have found that they can indeed code for proteins. The paper in Molecular Cell, Translation of CircRNAs, opens up a new window of functional possibilities for these oddball transcripts.
Circular RNAs (circRNAs) are abundant and evolutionarily conserved RNAs of largely unknown function. Here, we show that a subset of circRNAs is translated in vivo. By performing ribosome footprinting from fly heads, we demonstrate that a group of circRNAs is associated with translating ribosomes. Many of these ribo-circRNAs use the start codon of the hosting mRNA, are bound by membrane-associated ribosomes, and have evolutionarily conserved termination codons. Altogether, our study provides strong evidence for translation of circRNAs, revealing the existence of an unexplored layer of gene activity.
Evolutionarily conserved, of course, means not evolved. A laymans account in Science Daily explains the significance of this finding.
This discovery reveals an unexplored layer of gene activity in a type of molecule not previously thought to produce proteins. It also reveals the existence of a new universe of proteins not yet characterized.
One possible function for circRNAs is stable storage of protein-coding data for regions far from the nucleus. The tips of axons, for instance, can be too far away for quick access to genes they need. As circRNAs are extremely stable, they potentially could be stored for a long time in compartments more distant to the cells body like axons of neuron cells, Science Daily says. There, the RNA molecules could serve as a reservoir for proteins being produced at a given time. One scientist not connected about the research expressed excitement about it. This is a very important, promising and timely discovery that gives an important hint of the function of these abundant yet uncharacterized RNAs.
Interdependent Modifications
As geneticists explore the universe of epigenetic modifications, they have been unable to replicate some of them in a lab dish (in vitro). Now, a reason for this is coming to light. A paper in Nature begins with surprising statistics in the number of epigenetic modifications known. Then the authors tell how they discovered a case of interdependent modifications:
Nucleic acids undergo naturally occurring chemical modifications. Over 100 different modifications have been described and every position in the purine and pyrimidine bases can be modified; often the sugar is also modified. Despite recent progress, the mechanism for the biosynthesis of most modifications is not fully understood, owing, in part, to the difficulty associated with reconstituting enzyme activity in vitro. Whereas some modifications can be efficiently formed with purified components, others may require more intricate pathways. A model for modification interdependence, in which one modification is a prerequisite for another, potentially explains a major hindrance in reconstituting enzymatic activity in vitro. This model was prompted by the earlier discovery of tRNA cytosine-to-uridine editing in eukaryotes, a reaction that has not been recapitulated in vitro and the mechanism of which remains unknown.
Sure enough, they found a case in a microbe where one modification was a prerequisite to another modification. The mechanism appears to provide quality control by preventing catastrophic modifications to every matching spot on a whole genome.
Heres a case we can relate to. The human antibody response system rapidly mutates sequences looking for matches to antigens. How does activation-induced cytidine deaminase (AID) deaminate the immunoglobulin receptors (IgG) without affecting the rest of the genome? The answer may involve interdependent modifications:
In mammalian cells, AID plays a critical role in antibody class diversification by specifically targeting the IgG receptor genes, while generally leaving the rest of the genome unblemished. While the mechanism of this enzyme has been elucidated, the basis for its programmed specificity towards only a fraction of the genome is still unclear. The work presented here provides a rationale for controlling mutagenic enzymes through their interaction with other partners, as has been suggested previously. This, of course, leads to the question of how such substrate specificities evolved. Our data suggest that the answer may relate to the ability of certain proteinprotein interactions to provide secondary functions based on extreme mutual dependability, as illustrated here by the interplay between TRM140a and ADAT2/3.
ID advocates are certain to catch the phrases programmed specificity and extreme mutual dependency in support of their view, while chuckling at the Darwinists quandary about how such substrate specificities evolved. Their suggested solution only appears to dig a deeper hole. They never quite get around to telling readers how extreme mutual dependability came up with secondary functions by sheer dumb luck, such that the result only gives an appearance of programmed specificity. ID, on the other hand, provides a common-sense answer. Programming presupposes a programmer.
Image credit: Nogas1974 (Own work) [CC BY-SA 4.0], via Wikimedia Commons.
View original post here:
Electric DNA, Circular RNA, and Other Epigenetic Wonders - Discovery Institute
Posted in DNA
Comments Off on Electric DNA, Circular RNA, and Other Epigenetic Wonders – Discovery Institute
Just One Gram Of DNA Can Potentially Hold All The Data Stored On The Internet – Indiatimes.com
Posted: at 7:51 pm
Thats what scientists claim, anyways. What cant be ruled out is that humanitys creating and consuming massive amounts of data, and hard drives will very soon fall short of their ability to capture all of that data. This data storage problem is very real.
However, DNA-based hard drives can solve that problem easily, as DNA-based storage techniques are truly revolutionary.
A report claims that researchers have invented a brand new approach to encode digital data within DNA, thereby creating the highest-density data storage technique ever invented. Through this digital encoding technique, it is possible to store 215 petabytes (or 215 million gigabytes) of digital data in a single gram of DNA -- which is roughly the amount of data stored on the Internet. If that wasnt putting things into perspective, every bit of information stored and recorded by humans since the beginning of time can be effectively stored in a container about the size of a room.
DNA has many advantages over conventional magnetic hard drives or flash-based SSDs for storing digital data. DNA is highly dense, extremely compact and capable of lasting thousands of years if kept in a cool, dry place.
Last month, Erlich and Dina Zielinski, an associate scientist at the New York Genome Center, successfully managed to successfully encode binary data into a DNA strands genetic code, and then subsequently decode them into binary files that computers could read and display -- with the help of Twist Bioscience, a San Francisco-based startup working on the frontiers of digital and DNA-based data storage techniques, according to a report in Science Mag.
The DNA data embedding technique worked so that the new files contained absolutely no errors, according to the research published in Science.
DNA Code
The only roadblock in realizing the dream of storing digital data inside strands of DNA is the cost factor -- right now it takes about US $7000 to encode 2 MB of data in a DNA strand and an additionally $2000 to decode the data. As you can see, its insanely expensive.
But with the passage of time and enhanced scalability, the DNA storage technique will no doubt become the storage technology of the future.
See the original post here:
Just One Gram Of DNA Can Potentially Hold All The Data Stored On The Internet - Indiatimes.com
Posted in DNA
Comments Off on Just One Gram Of DNA Can Potentially Hold All The Data Stored On The Internet – Indiatimes.com
DNA from 36-year-old gum leads to cold case manslaughter conviction – Fox News
Posted: at 7:51 pm
Talk about a long-lasting piece of gum.
A 60-year-old British man was convicted of manslaughter in March after investigators pulled traces of his DNA from a 36-year-old piece of gum left behind at the crime scene and a letter he later sent in an attempt to deflect blame.
Osmond Bell was sentenced to 12 years in prison on March 22 for the 1981 murder of Nova Welsh, an ex-lover of Bells with whom he had two children. The jury acquitted Bell of the more serious murder charge after the six-week trial.
Welsh was 24 and dating a new boyfriend when a jealous Bell used forced on her neck, which in fact killed her, Judge Patrick Thomas said, according to The Sun.
Bell then stuffed Welshs body in a cabinet. But his crucial mistake was leaving behind a piece of gum, which was used to seal the cupboards lock.
Having killed her, you concealed her body, doing nothing to assuage the pain and grief of your own children, Thomas said.
Bell was first arrested in 1981; however, he was eventually let go due to a lack of evidence. But advances in technology provided the proof needed to bring him to justice.
The family can now have closure knowing the person who took Novas life has been brought to justice, Novas mom, Lorna Welsh, told the BBC.
Visit link:
DNA from 36-year-old gum leads to cold case manslaughter conviction - Fox News
Posted in DNA
Comments Off on DNA from 36-year-old gum leads to cold case manslaughter conviction – Fox News
Is the mother to blame in a child with eczema? – Temple Daily Telegram
Posted: at 7:50 pm
Jonathan is a 10-month-old child who has been developing an itchy rash on the face, elbows and knees. His skin in these areas looks red, dry and scaly. He has also been scratching these areas frequently. After a yellow crust was noted and his mom took him to the pediatrician she was told he has atopic dermatitis, a form of eczema. She asks the doctor what might have caused this.
Atopic dermatitis, also known as eczema, is a common skin condition which affects 1 in 10 children. While it is well known that family history of atopy (eczema, asthma, or seasonal allergies) are risk factors for eczema, the exact cause of eczema remains a mystery.
An online service is needed to view this article in its entirety. You need an online service to view this article in its entirety.
If you have previously registered on tdtnews.com, and have a current online subscription you may login with your email and password. Online subscribers get access to all of the Temple Daily Telegram's online content, plus a digital replica of the print edition. Some third party content, including circulars may not be available online.
If you have questions regarding access, please contact circulation at tdtcir@tdtnews.comor 254-778-4444 between 8 a.m. and 5 p.m. Monday through Friday.
Need an account? Create one now.
kAmpD >65:42= @H=6586 4@?E:?F6D E@ 25G2?46[ >@C6 2?5 >@C6 DEF5:6D 2C6 36:?8 4@?5F4E65 E@ ECJ E@ 7:?5 4FC6D 7@C 4@>>@? 5:D62D6D DF49 2D 64K6>2] $4:6?E:DED 92G6 366? =@@<:?8 2E 49:=5C6? =:G:?8 H:E9 64K6>2 2?5 82E96C:?8 :?7@C>2E:@? 23@FE E96> 2D 72C 324< 2D 367@C6 E96J H6C6 3@C?] %9:D :D 36:?8 5@?6 E@ 6IA=@C6 H96E96C AC6?2E2= 6IA@DFC6D :?7=F6?46 E96 56G6=@A>6?E @7 E9:D D6?D:E:G6 D<:? 4@?5:E:@?]k^Am
kAm%96C6 H2D 2 C646?E DEF5J =@@<:?8 2E E96 67764E @7 DEC6DD 5FC:?8 AC68?2?4J 2?5 E96 DF3D6BF6?E C:D< @7 64K6>2 😕 E96 49:=5] xE H2D 4@?4=F565 E92E >2E6C?2= 56AC6DD:@? 2?5 2?I:6EJ 5FC:?8 AC68?2?4J H2D 2DD@4:2E65 H:E9 😕 =2C86C 2>@F?ED @7 DEC6DD 496>:42=D EC2?D>:EE65 E9C@F89 E96 A=246?E2[ A@DD:3=J EC:886C:?8 2 9:896C C:D< @7 64K6>2 😕 E96 49:=5] u:?5:?8D DF49 2D E96D6 2C6 2E C:D< 7@C 36:?8 >:D:?E6CAC6E65 3J E96 AF3=:4]k^Am
kAmpD DEF5:6D =:<6 E96D6 2C6 C6=62D65[ :E :D :>A@CE2?E E@ C6>6>36C E92E E96 AFCA@D6 😀 ?@E A=246 3=2>6 @? E96 >@E96C] $EF5:6D =:<6 E9:D 2C6 >62?E E@ C6>:?5 FD @7 E96 :>A@CE2?46 @7 2AAC@AC:2E6 AC6?2E2= 42C6 2?5 E@ 255C6DD ?@E @?=J E96 A9JD:42= 962=E9 @7 E96 >@E96C 2?5 323J[ 3FE E96:C 6>@E:@?2= 962=E9 2D H6==] tG6CJ AC6?2E2= G:D:E D9@F=5 :?4=F56 2? 6G2=F2E:@? @7 E96 >@E96CD >@@5 2?5 >6?E2= DE2E6] x7 2?J 4@?46C?D 2C:D6[ C6D@FC46D 42? 2?5 D9@F=5 36 2AAC@AC:2E6=J AC@G:565] %96D6 DEF5:6D DF886DE E92E 😕 5@:?8 D@[ E96 C2E6D @7 5:D62D6D DF49 2D 64K6>2 >2J DE2CE E@ 564=:?6]k^Am
kAm#2E96C E92? 3=2>:?8 E96 >@E96C[ H6 D9@F=5 36 7@4FD:?8 @? H9J >@E96CD 2C6 F?56C D@ >F49 DEC6DD 5FC:?8 AC68?2?4J 2?5 :>AC@G:?8 4@?5:E:@?D 4C62E:?8 E92E DEC6DD] %96C6 2C6 >2?J D:?8=6 >@E96CD H9@ 2C6 E96 D@=6 AC@G:56CD 7@C E96 72>:=J[ H@C<:?8 7F== E:>6 2?5 E96? DA6?5:?8 4@F?E=6DD 9@FCD 4@>A=6E:?8 9@FD6H@C< 2?5 A6C92AD E2<:?8 42C6 @7 @E96C 49:=5C6?]k^Am
kAm%96C6 2C6 H@>6? H9@ >2J 36 DF776C:?8 7C@> 56AC6DD:@? 2?5 2?I:6EJ AC:@C E@ 364@>:?8 AC68?2?E 2?5 5@ ?@E C646:G6 2AAC@AC:2E6 EC62E>6?E] xE 😀 :>A@CE2?E E@ C64@8?:K6 E92E 56AC6DD:@? 2?5 2?I:6EJ 27764E >@C6 E92? ;FDE E96 962=E9 @7 E96 >@E96C[ 3FE >2J 92G6 =@?8 E6C> 4@?D6BF6?46D 7@C E96 F?3@C? 49:=5]k^Am
kAm%9:D 2CE:4=6 😀 ?@E :>A=J:?8 E92E :7 J@FC 49:=5 92D 64K6>2[ :E 😀 3642FD6 J@F H6C6 DEC6DD65 5FC:?8 AC68?2?4J] t4K6>2 56G6=@AD 2D 2 C6DF=E @7 >F=E:A=6 724E@CD E92E 2C6 DE:== 36:?8 DEF5:65[ 3FE A6C92AD DEC6DD 5FC:?8 AC68?2?4J 😀 ;FDE @?6 4@?EC:3FE:?8 724E@C] x7 J@F 2C6 AC68?2?E[ @C @H D@>6@?6 H9@ :D[ :E 😀 :>A@CE2?E E92E H6 E2<6 E:>6 E@ AC@E64E 2?5 42C6 7@C E96 >6?E2= 962=E9 @7 E96 >@E96C] %2=< E@ J@FC 5@4E@C 2?5 J@FC 49:=5D A65:2EC:4:2? 23@FE 2?JE9:?8 E92E >2J 36 C6DF=E:?8 😕 :?4C62D65 DEC6DD 2?5 D66< C6D@FC46D E@ 96=A C6=:6G6 @C :>AC@G6 5:D62D6D @7 >6?E2= 962=E9]k^Am
kAmsC] |682? u@DE6C 😀 2 A65:2EC:4 C6D:56?E 2E |4{2?6 r9:=5C6?D w@DA:E2=]k^Am
Excerpt from:
Is the mother to blame in a child with eczema? - Temple Daily Telegram
Posted in Eczema
Comments Off on Is the mother to blame in a child with eczema? – Temple Daily Telegram
New Eczema Drug Brings Long-Awaited Relief – University of Rochester Newsroom
Posted: at 7:50 pm
Although its the most common skin disease in the world, theres been no safe, effective treatment for people who suffer from moderate-to-severe eczema. UR Medicine Dermatologist Dr. Lisa Beck explains how a new drug will be life-changing for many.
Imagine having a severe case of poison ivy covering half of your body that, despite everything you try, never goes away. Thats what life is like for people with moderate-to-severe eczema or atopic dermatitis (AD).
Its the reason we are so excited about the FDAs approval of Dupilumab, a drug weve tested at URMC for years in our quest to help people whose lives are disrupted by this level of AD.
AD impacts 7 to 9 percent of adults who suffer from severely dry skin, red lesions that may crust or ooze, skin thickening and intense itching, which may lead to skin wounds, infections, sleep disturbance and depression.
About 3 percent of adults have moderate-to-severe disease and have had to rely on topical prescription treatments and even oral steroids that provided temporarily relief at best and are not safe for long-term use. Since most adults with AD have had their disease for decades, these tools didnt offer a long-term solution; patients felt desperate and the doctors who care for them felt frustrated by their inability to ease their suffering.
The new drug, Dupilumab, is a biologic given by injection. It works by blocking the actions of two proteins in the body that play a key in role AD. Its the first systemic (non-steroid) drug for AD and, unlike topical medications that act locally, it affects allergic inflammation in all organs. People with AD are also more likely to have asthma and other allergic disorders such as hay fever which, for many, the new drug also appears to help.
This is a watershed moment for the treatment of adults with AD, some of whom have been suffering for decades with intractable itch and extensive skin disease. Until now, weve had nothing new to offer them so this is a real game-changer.
Were fortunate to have been part of the earliest testing of this drug, including a three-year trial to test its efficacy and safety. These clinical trials showed that Dupilumab rapidly and significantly improved the skin appearance and the severity of itch in patients with few side effects.
Dupilumab, which will be sold under the name Dupixent, was approved by the FDA on March 28, 2017. It typically takes one to three weeks from FDA approval before a drug becomes available for doctors to prescribe.
If youre interested in being evaluated for AD, please call (585) 275-7546.
Studies to test the safety and efficacy of the drug in children 12 to 18 years of agewill begin enrollment soon at our Dermatology Clinical Trials Unit. If you are interested, please call (585) 275-0374.
Lisa Beck, M.D., Deans Professor of Dermatology at URMC, has more than 20 years of experience in studying and treating atopic dermatitis and eczema. She has served as a consultant with Regeneron and Sanofi, who funded the Dupilumab studies.
By Lori Barrette on April 03, 2017
Welcome to Health Matters, a blog aimed at keeping you and your family healthy. Visit often and invite your family and friends to check us out. Want our health tips delivered right to your inbox? Sign up for the Health Matters newsletter.
We welcome your feedback and encourage your comments.
Though health advice offered here is provided by experts, there is no substitute for the personal care your own provider can offer. If you have medical questions or concerns, please contact your physician.
Originally posted here:
New Eczema Drug Brings Long-Awaited Relief - University of Rochester Newsroom
Posted in Eczema
Comments Off on New Eczema Drug Brings Long-Awaited Relief – University of Rochester Newsroom
Goal of psoriasis care is symptom control with least toxic treatment … – Sarasota Herald-Tribune
Posted: at 7:49 pm
Dear Dr. Roach: I have psoriasis. I have used clobetasol for 22 years. The psoriasis is not severe, but its constant. Should I be concerned about using this treatment for so many years? The only time it cleared up (and that was for two years) was when I had to take steroids for poison ivy. The doctor would not put me on a low dose of steroid to see if the psoriasis would stop completely and will not use other treatments, because both my brother and sister died of cancer. Any suggestions? I had two co-workers with psoriasis that was much worse than mine, and for some reason it disappeared for both of them after 20 years. R.M.
Dear R.M.: For mild to moderate psoriasis, a skin disorder that most commonly manifests with scaly plaques, the goal of care is to control symptoms using the least toxic therapies available. That means topical therapies, like clobetasol cream or ointment, and other treatments for instance, vitamin D-like or vitamin A-like drugs. These are very safe to use long-term for most people, if used correctly under supervision (clobetasol, a powerful steroid, used in the wrong place, especially the face, can cause permanent atrophy). If you have had good response to these, they are your best choice. However, it sounds like you havent had as good a response as you want.
I am curious about your response to the oral steroids you took for poison ivy. Normally, we treat moderate to severe poison ivy with a week or so of oral steroids. If just that much gave you two years of freedom from psoriasis, then I dont understand why your doctor cant give you a short course of steroids on a very-infrequent basis.
For severe psoriasis, systemic treatments are essential; however, they do have risks. Steroids are not a usual systemic treatment for psoriasis. Methotrexate, a drug used for cancer and in serious autoimmune diseases, is well-studied and tolerated by most. Vitamin A relatives, like acitretin (Soriatane), are very effective. Biological therapies, like etanercept (Enbrel), also have a clear place in treating severe psoriasis, but all of these drugs have potential for harm, including an increased risk of certain types of cancer.
In your case, I would consider getting a second opinion from a dermatologist with expertise in psoriasis. If the advice is the same, you can feel confident in the advice; if not, you will need to decide which course to follow.
Dear Dr. Roach: You recently had a column where you did not recommend alprazolam (Xanax) as a long-term sleep aid. What are the negative effects of using it that way? A.T.
Dear A.T.: Alprazolam is in the class of drugs called benzodiazepines, which includes Valium, Klonopin and Halcyon. They are effective at getting people to sleep more quickly, and increase total sleep time by 30-60 minutes. Alprazolam is very short-acting (although there is a long-acting form now) and is not indicated for insomnia.
I dont recommend benzodiazepines because they increase the rate of falls, especially in the elderly, because they can cause memory loss and because they can cause confusion and dependence.
I try to avoid prescribing sleeping medications, and most people with occasional difficulty sleeping do well with sleep hygiene advice: Having a regular sleep schedule, not trying to force sleep, avoiding alcohol and caffeine near bedtime and not using bright lights or computer screens before bed are part of this. If I do prescribe a sleep medication, I recommend using it no more than every other day and for no more than two weeks. People who need more than that, I refer to a sleep specialist.
Readers may email questions to ToYourGoodHealth@med.cornell.edu.
Visit link:
Goal of psoriasis care is symptom control with least toxic treatment ... - Sarasota Herald-Tribune
Posted in Psoriasis
Comments Off on Goal of psoriasis care is symptom control with least toxic treatment … – Sarasota Herald-Tribune
Psoriasis, often misdiagnosed, may lead to heart disease and other serious ailments – Miami Herald
Posted: at 7:49 pm
Miami Herald | Psoriasis, often misdiagnosed, may lead to heart disease and other serious ailments Miami Herald For many people, this can lead to a misdiagnosis or undertreatment of psoriasis, which can lead to serious health complications including an increased risk for heart disease. Fortunately, there are many new medications that can help treat skin symptoms ... 7 Things People With Psoriasis Want You to Know - SheKnows Lower Psoriasis Area, Severity Scores for Women Versus Men |
Read the original:
Psoriasis, often misdiagnosed, may lead to heart disease and other serious ailments - Miami Herald
Posted in Psoriasis
Comments Off on Psoriasis, often misdiagnosed, may lead to heart disease and other serious ailments – Miami Herald
2017 Global Gene Medicine Therapy Market in North America … – Edition Time
Posted: at 7:48 pm
Market.Biz: The Global Gene Medicine Therapy Market Research Report 2017 offers a comprehensive study on Gene Medicine Therapy Industry including the current Gene Medicine Therapy market trends and market status. The Gene Medicine Therapy Report focuses on the market in major continents, Like North America Gene Medicine Therapy Market, Gene Medicine Therapy market in Europe and Asia Gene Medicine Therapy market etc along with main countries like United States, Germany, Japan and China etc. on Gene Medicine Therapy market scenario.
2017 Global Gene Medicine Therapy Market is expected to register a CAGR of XX.XX % during forecast period.
1) Major key Manufacturers working in Gene Medicine Therapy industry is also mentioned. 2) 2017 Worldwide Gene Medicine Therapy market estimated at USD XXXX in 2016. 3) 2017 Global Gene Medicine Therapy industry projected to reach USD XXXX million at forecast period. 4) Worldwide Gene Medicine Therapy market projected to grow at CAGR XXXX % During forecast period. 5) Gene Medicine Therapy Market (in North America, Europe and Asia) expected to grow at CAGR of XXXX % over the forecast period.
Do Inquiry Before Purchasing Report Here:https://market.biz/report/global-gene-medicine-therapy-market-2017-9dimen/67047/#inquiry
At an initial stage, the Gene Medicine Therapy market report covers the Gene Medicine Therapy basic information including Gene Medicine Therapy definitions, Gene Medicine Therapy market classifications, a wide range of applications and Gene Medicine Therapy industry chain framework. The Gene Medicine Therapy Report also covers industry development plans and policies, Gene Medicine Therapy product specification, Gene Medicine Therapy manufacturing process and price structures. Then the report focuses on a deep study of global factors influencing the Gene Medicine Therapy market like market revenue, product cost, Gene Medicine Therapy market volume, utilization ratio along with Gene Medicine Therapy market demand and supply analysis.
At a later stage, the report presents, Gene Medicine Therapy market SWOT Analysis, feasibility study related to Gene Medicine Therapy market future investment plans and Gene Medicine Therapy market investment return analysis are employed to study the Gene Medicine Therapy industry on a global scale.
In short, Gene Medicine Therapy report is overall research study on Gene Medicine Therapy industry. Special Thanks to the help and support from Gene Medicine Therapy industry technical experts and marketing experts for their valuable contribution in Research Team Survey and Interviews
Request For Sample Report Here:https://market.biz/report/global-gene-medicine-therapy-market-2017-9dimen/67047/#requestforsample
The Gene Medicine Therapy market research report consists of six sections, the first section includes about Gene Medicine Therapy basic product information; the second section includes the analysis of Asias Gene Medicine Therapy industry; in third section analysis of North American Gene Medicine Therapy industry is done; in the fourth section analysis of Europe Gene Medicine Therapy industry; in the fifth section the study related to Gene Medicine Therapy market entry and feasibility of investment study is done; in sixth section the valuable research conclusions related to Gene Medicine Therapy industry are listed.
The rest is here:
2017 Global Gene Medicine Therapy Market in North America ... - Edition Time
Posted in Gene Medicine
Comments Off on 2017 Global Gene Medicine Therapy Market in North America … – Edition Time
Canopy acquires gene-editing technology license – St. Louis Business Journal
Posted: at 7:48 pm
Stunning Contemporary Gem
Dave Smoller co-founded Canopy Biosciences
Dilip Vishwanat
Canopy Biosciences, a young startup looking to accelerate the commercialization of life science medical tools and services, has exclusively licensed a gene-editing technology from Washington University in St. Louis and Johns Hopkins University.
The company, which raised$2 million from investors earlier this year, was co-founded by Dave Smoller and is led by CEO and President Edward Weinstein. Smoller and Weinstein worked together at Sigma-Aldrich before the company was sold to Merck KGaA in November 2015 for $17 billion.
Dave Smoller co-founded Canopy Biosciences
Dilip Vishwanat
Canopy looks to in-license essentially a collaboration agreement between two parties in which one company performs research and development technologies in the fields of genetic engineering and personalized medicine.
The licensed technology is called Tunr and it targets translation elongation by introducing consecutive adenosine nucleotides into a gene coding sequence of interest, according to a release.
Excerpt from:
Canopy acquires gene-editing technology license - St. Louis Business Journal
Posted in Gene Medicine
Comments Off on Canopy acquires gene-editing technology license – St. Louis Business Journal
Toronto doctors identify new disease in children caused by defective gene – Medicine Hat News
Posted: at 7:48 pm
By Sheryl Ubelacker, The Canadian Press on April 3, 2017.
TORONTO Daniel Nevins-Selvadurais case had doctors at Torontos Hospital for Sick Children baffled. At age three, he had developed blood in his stool, a sign of possible hereditary inflammatory bowel disease. But testing for all the genetic mutations known to cause the condition came back negative.
As he grew older, Daniels symptoms became more diverse. He developed unusual rashes and painful lumps in his legs, as well as having an abnormally high white cell count and low platelets in his blood, pointing to an unidentified problem with his immune system.
A host of doctors at the hospital among them specialists in blood disorders, cancer, rheumatology, immunology and gastroenterology couldnt pin down the cause of the childs illness.
Nobody could give us a diagnosis, so he was passed from one specialist to another over the years and various people did various tests, said his mother, Christina Arulrajah. He showed signs of so many different diseases.
Still, Dr. Aleixo Muise, a gastroenterologist who had been seeing Daniel for his inflammatory bowel disease, or IBD, said that because of the boys wide-ranging symptoms all the doctors thought that he must have a genetic cause to his disease.
Then in 2014, a team led by Muise launched a project to explore the genetic basis of IBD, using an advanced technology for studying patients DNA. Daniels genome was among those investigated using a technique called whole-exome sequencing.
It was then that they had their eureka moment.
Testing of Daniels genome turned up a mutation never before seen. The defect was in a gene known as ARPC1B, which produces a protein the bodys cells need to change shape, move, divide and perform other vital functions.
His ARPC1B gene was expressing none of this critical protein.
ARPC1B, we know, plays a very important role in the immune system and how different cells in the body mostly found in the blood work, said Muise.
Sometimes its surprising that one defect causes such widespread different types of disease in one patient, but this one mutation explains all the problems Daniel had.
The Sick Kids team subsequently discovered two other patients who were related to each other but not to Daniel, who also had a mutation that left them with very little ARPC1B protein. Since then, about 20 children worldwide have been identified with the genetic mutation.
It gave us enough evidence to know that this was a brand new disease that hadnt been described before, said Muise.
The discovery of whats been dubbed ARPC1B syndrome is described in Mondays edition of the journal Nature Communications.
Daniel was over the moon to get a diagnosis, said his mother. When they found out what was wrong, it was a real relief.
In his mind, its all about the cure. Now that theres a diagnosis, theres now going to be a cure.
His doctors believe a bone-marrow transplant will give Daniel new blood cells including immune cells that wont carry the genetic mutation. A search is now on for an appropriate donor for the 10-year-old.
If you do a bone-marrow transplant or you replace his immune system, this should cure him of his disease, said Muise.
Daniels mother said shes still trying to get her head around the notion of a cure after watching her son deal with so many health issues since infancy, the worst of which was seeing him repeatedly in pain.
While we have never let his illness define him, and he remains a very positive and energetic boy, it was always on the back of his mind, Arulrajah said of her soccer-loving son.
She hopes a successful bone-marrow transplant will mean an end to all the medications Daniel has had to take to treat his various symptoms over the years, including long courses of a steroid that have affected his growth.
It would be absolutely fantastic.
-Follow @SherylUbelacker on Twitter.
You must be logged in to post a comment.
Read more:
Toronto doctors identify new disease in children caused by defective gene - Medicine Hat News
Posted in Gene Medicine
Comments Off on Toronto doctors identify new disease in children caused by defective gene – Medicine Hat News